Prestige Consumer Healthcare
250 hedge funds and large institutions have $2B invested in Prestige Consumer Healthcare in 2020 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 77 increasing their positions, 88 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
12.18% less ownership
Funds ownership: 120.72% → 108.54% (-12%)
13% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 88
18% less capital invested
Capital invested by funds: $2.46B → $2B (-$454M)
Holders
250
Holding in Top 10
2
Calls
$1.45M
Puts
$66K
Top Buyers
1 | +$7.85M | |
2 | +$6.74M | |
3 | +$5.84M | |
4 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$4.59M |
5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$4.57M |
Top Sellers
1 | -$75.3M | |
2 | -$56.6M | |
3 | -$26.5M | |
4 |
Goldman Sachs
New York
|
-$17.6M |
5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$12M |